Assenagon Asset Management S.A. Jazz Pharmaceuticals PLC Transaction History

Assenagon Asset Management S.A.

$47.8 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	SELL	$103.94 - $118.98 $159,443 - $182,515	-1,534 Reduced 8.27%	17,017 $1.82 Million
Q1 2024 Apr 24, 2024	SELL	$115.19 - $132.77 $11,288 - $13,011	-98 Reduced 0.53%	18,551 $2.23 Million
Q4 2023 Jan 17, 2024	SELL	$114.26 - $136.0 $22,166 - $26,384	-194 Reduced 1.03%	18,649 $2.29 Million
Q3 2023 Nov 06, 2023	SELL	$122.0 - $145.31 $52,704 - $62,773	-432 Reduced 2.24%	18,843 $2.44 Million
Q2 2023 Jul 25, 2023	SELL	$122.5 - $147.16 $1.22 Million - $1.46 Million	-9,923 Reduced 33.99%	19,275 $2.39 Million
Q1 2023 Apr 18, 2023	BUY	$133.98 - $160.47 $3.61 Million - $4.33 Million	26,962 Added 1205.81%	29,198 $4.27 Million
Q4 2022 Jan 12, 2023	SELL	$129.72 - $159.85 $484,763 - $597,359	-3,737 Reduced 62.56%	2,236 $356,000
Q3 2022 Oct 27, 2022	SELL	$126.59 - $161.18 $5.13 Million - $6.53 Million	-40,487 Reduced 87.14%	5,973 $796,000
Q2 2022 Jul 27, 2022	BUY	$141.59 - $168.66 $5.92 Million - $7.05 Million	41,794 Added 895.71%	46,460 $7.25 Million
Q1 2022 Apr 25, 2022	SELL	$129.64 - $160.7 $17.9 Million - $22.2 Million	-137,936 Reduced 96.73%	4,666 $726,000
Q4 2021 Feb 01, 2022	BUY	$119.87 - $145.67 $16.7 Million - $20.3 Million	139,073 Added 3940.86%	142,602 $18.2 Million
Q3 2021 Oct 19, 2021	SELL	$128.64 - $184.79 $6.62 Million - $9.5 Million	-51,431 Reduced 93.58%	3,529 $460,000
Q2 2021 Jul 15, 2021	BUY	$160.2 - $186.42 $3.8 Million - $4.42 Million	23,717 Added 75.91%	54,960 $9.76 Million
Q1 2021 Apr 26, 2021	BUY	$150.19 - $173.5 $4.69 Million - $5.42 Million	31,243 New	31,243 $5.14 Million
Q3 2020 Oct 07, 2020	SELL	$105.46 - $144.13 $945,132 - $1.29 Million	-8,962 Closed	0 $0
Q2 2020 Jul 21, 2020	SELL	$95.68 - $121.88 $1.85 Million - $2.35 Million	-19,308 Reduced 68.3%	8,962 $989,000
Q1 2020 Apr 17, 2020	SELL	$87.74 - $152.74 $12.9 Million - $22.5 Million	-147,551 Reduced 83.92%	28,270 $2.82 Million
Q4 2019 Jan 17, 2020	BUY	$117.65 - $153.73 $17.7 Million - $23.1 Million	150,122 Added 584.16%	175,821 $26.2 Million
Q3 2019 Oct 16, 2019	SELL	$125.18 - $143.24 $18.9 Million - $21.6 Million	-150,967 Reduced 85.45%	25,699 $3.29 Million
Q2 2019 Aug 12, 2019	BUY	$125.55 - $144.48 $20.7 Million - $23.9 Million	165,249 Added 1447.39%	176,666 $25.2 Million
Q1 2019 Apr 26, 2019	BUY	$121.81 - $142.95 $1.39 Million - $1.63 Million	11,417 New	11,417 $1.63 Million
Q1 2018 Apr 30, 2018	SELL	$135.59 - $157.16 $570,833 - $661,643	-4,210 Closed	0 $0
Q4 2017 Jan 25, 2018	BUY	$131.06 - $150.39 $551,762 - $633,141	4,210	4,210 $567,000

Others Institutions Holding JAZZ

# of Institutions

511

Shares Held

57.8M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.63B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.

Account